Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

膀胱切除术 医学 膀胱癌 危险系数 倾向得分匹配 比例危险模型 泌尿科 内科学 累积发病率 回顾性队列研究 置信区间 入射(几何) 队列 癌症 肿瘤科 外科 物理 光学
作者
Pietro Scilipoti,Mattia Longoni,Mario de Angelis,Paolo Zaurito,Aleksander Ślusarczyk,Francesco Soria,Benjamin Pradere,Wojciech Krajewski,David D‘Andrea,Andrea Mari,Francesco Del Giudice,Renate Pichler,José Daniel Subiela,Gautier Marcq,Andrea Gallioli,Luca Afferi,Riccardo Mastroianni,Giuseppe Simone,Simone Albisinni,Laura S. Mertens
出处
期刊:BJUI [Wiley]
卷期号:136 (1): 47-54 被引量:7
标识
DOI:10.1111/bju.16675
摘要

Objective To assess the oncological outcomes of patients with high‐risk (HR) and very high‐risk (VHR) non‐muscle‐invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette–Guérin (BCG) instillations from a contemporary European multicentre cohort. Patients and Methods We conducted a retrospective analysis of 1491 patients diagnosed with HR‐ or VHR‐NMIBC from a European multicentre database between 2015 and 2024. Patients were included if they received either upfront RC or at least five doses of BCG. A 1:1 propensity score matching (PSM) according to clinically relevant variables was applied. Progression was defined as muscle‐invasive or metastatic disease. Cumulative incidence plots and multivariable competing risk regression models addressing cancer‐specific mortality (CSM) were fitted. Results Among the 1221 patients with HR‐ ( n = 1221 [90%]) or VHR‐NMIBC ( n = 121 [10%]), 87 (7.1%) underwent upfront RC. The median follow‐up was 2.6 years. After PSM (87 vs 87 patients), the 5‐year CSM rate was similar in patients treated with BCG (13%) vs their upfront RC counterparts (16%) (hazard ratio: 1.77, 95% confidence interval [CI] 0.66–4.73; P = 0.3). Of the 1134 patients who initially received BCG, 73 (6.6%) eventually required delayed RC, with 34 (47%) progressing to muscle‐invasive bladder cancer before delayed RC. The 3‐year CSM rate was comparable in upfront RC (13%) vs delayed RC (11%) among non‐progressing patients ( P = 0.3). However, patients who progressed before delayed RC had worse 3‐year CSM relative to those who did not (13% vs 31%, hazard ratio: 0.32, 95% CI 0.13–0.83; P = 0.018). Conclusion Within a European cohort of patients with HR‐ and VHR‐NMIBC, upfront RC was rarely performed. Patients treated with BCG did not exhibit a CSM disadvantage relative to their upfront RC counterparts. After matching, long‐term CSM was similar between BCG therapy and upfront RC. Delayed RC, led to worse outcomes if performed after progression, but matched upfront RC when performed before progression, underscoring importance of timely surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
懒回顾完成签到,获得积分10
刚刚
鲸鱼完成签到,获得积分10
2秒前
Anna完成签到,获得积分10
2秒前
Syanx_8完成签到,获得积分10
2秒前
2秒前
哈哈完成签到,获得积分10
2秒前
mkl发布了新的文献求助10
3秒前
木子完成签到 ,获得积分10
3秒前
4秒前
酷炫安雁完成签到,获得积分10
4秒前
Orange的应助被Robin007采纳,获得10
4秒前
5秒前
PYF完成签到,获得积分10
5秒前
五五完成签到,获得积分10
5秒前
小字完成签到,获得积分10
5秒前
5秒前
DDYYFF完成签到,获得积分10
5秒前
黄立伟完成签到,获得积分10
5秒前
brynn完成签到 ,获得积分10
6秒前
迈巴贺完成签到,获得积分10
6秒前
小马甲的应助被li采纳,获得10
6秒前
molihuakai的应助被li采纳,获得10
6秒前
南风喜欢完成签到,获得积分10
6秒前
可爱的函函的应助被碧蓝中恶采纳,获得10
6秒前
尊敬的雪旋完成签到 ,获得积分10
6秒前
WYH发布了新的文献求助10
7秒前
369ninja发布了新的文献求助10
7秒前
喝口可乐的应助被Wkk采纳,获得10
8秒前
葳蕤墨绿完成签到,获得积分10
8秒前
YY完成签到,获得积分10
8秒前
skskysky完成签到,获得积分10
8秒前
9秒前
zzs喵完成签到,获得积分10
9秒前
9秒前
匍匐前进完成签到,获得积分10
10秒前
ZsJJkk发布了新的文献求助10
11秒前
11秒前
不勤劳的小蜜蜂完成签到,获得积分10
11秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162